Last Updated: 12/03/2025
Alpha-PBO LLIN Phase I and Phase II Support
Objectives
To produce Phase I and Phase II data for evaluation of a new alphacypermethrin-PBO LLIN
Principal Institution
Principal Investigators / Focal Persons
External reference
Date
Aug 2020 — Sep 2022
Total Project Funding
$250,291
Funding Details
Gates Foundation (GF), United States
Grant ID: INV-022988
Project Site
Related Resources
